Mark Muzi

6.7k total citations
116 papers, 4.3k citations indexed

About

Mark Muzi is a scholar working on Radiology, Nuclear Medicine and Imaging, Cancer Research and Genetics. According to data from OpenAlex, Mark Muzi has authored 116 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Radiology, Nuclear Medicine and Imaging, 44 papers in Cancer Research and 31 papers in Genetics. Recurrent topics in Mark Muzi's work include Medical Imaging Techniques and Applications (87 papers), Cancer, Hypoxia, and Metabolism (37 papers) and Glioma Diagnosis and Treatment (31 papers). Mark Muzi is often cited by papers focused on Medical Imaging Techniques and Applications (87 papers), Cancer, Hypoxia, and Metabolism (37 papers) and Glioma Diagnosis and Treatment (31 papers). Mark Muzi collaborates with scholars based in United States, Ireland and Czechia. Mark Muzi's co-authors include David A. Mankoff, Kenneth A. Krohn, Alexander M. Spence, Jeanne M. Link, Finbarr O’Sullivan, Lanell M. Peterson, John R. Grierson, Michael M. Graham, Joseph G. Rajendran and Hubert Vesselle and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American Statistical Association.

In The Last Decade

Mark Muzi

112 papers receiving 4.3k citations

Peers

Countries citing papers authored by Mark Muzi

Since Specialization

Citations

This map shows the geographic impact of Mark Muzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Muzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Muzi more than expected).

Fields of papers citing papers by Mark Muzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Muzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Muzi. The network helps show where Mark Muzi may publish in the future.

Co-authorship network of co-authors of Mark Muzi

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Muzi. A scholar is included among the top collaborators of Mark Muzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Muzi. Mark Muzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Equivalent uniform aerobic dose in radiotherapy for hypoxic tumors 2024 ·Physics in Medicine and Biology ·Alexei V. Chvetsov, Mark Muzi	1
2	Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials 2024 ·EJNMMI Research ·Mark Muzi, Lanell M. Peterson, Jennifer M. Specht, Daniel S. Hippe, Alena Novakova-Jiresova, Jean H. Lee, Brenda F. Kurland, David A. Mankoff, Nancy A. Obuchowski, Hannah M. Linden, Paul E. Kinahan	0
3	Increased [ ¹⁸ F]Fluorodeoxyglucose Uptake in the Left Pallidum in Military Veterans with Blast-Related Mild Traumatic Brain Injury: Potential as an Imaging Biomarker and Mediation with Executive Dysfunction and Cognitive Impairment 2024 ·Journal of Neurotrauma ·Garth E. Terry, Kathleen F. Pagulayan, Mark Muzi, Cynthia Mayer, (unknown), Abigail G. Schindler, Todd L. Richards, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jason P. Mihalik, Ronald G. Thomas, Murray A. Raskind, Elaine R. Peskind, James S. Meabon	1
4	Evaluation of Apparent Diffusion Coefficient Repeatability and Reproducibility for Preclinical MRIs Using Standardized Procedures and a Diffusion-Weighted Imaging Phantom 2023 ·Tomography ·Dariya Malyarenko, (unknown), Stephen Pickup, Rong Zhou, (unknown), Seth T. Gammon, Kooresh I. Shoghi, James D. Quirk, Renuka Sriram, Peder E. Z. Larson, Michael T. Lewis, Robia G. Pautler, Paul E. Kinahan, Mark Muzi, Thomas L. Chenevert	4
5	Patient-Adaptive Population-Based Modeling of Arterial Input Functions 2022 ·IEEE Transactions on Medical Imaging ·(unknown), Mark Muzi, Jian Huang, Eric Wolsztynski	4
6	Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions 2022 ·Journal of Nuclear Medicine ·Austin R. Pantel, Varsha Viswanath, Mark Muzi, Robert K. Doot, David A. Mankoff	7
7	Whole-Body [18F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687 2021 ·Tomography ·Mark Muzi, Finbarr O’Sullivan, (unknown), (unknown), David A. Mankoff, (unknown), (unknown), Evan Y. Yu	1
8	Quantifying Bias and Precision of Kinetic Parameter Estimation on the PennPET Explorer, a Long Axial Field-of-View Scanner 2020 ·IEEE Transactions on Radiation and Plasma Medical Sciences ·Varsha Viswanath, Austin R. Pantel, Margaret E. Daube-Witherspoon, Robert K. Doot, Mark Muzi, David A. Mankoff, Joel S. Karp	18
9	Assessment of the Prognostic Value of Radiomic Features in 18F-FMISO PET Imaging of Hypoxia in Postsurgery Brain Cancer Patients: Secondary Analysis of Imaging Data from a Single-Center Study and the Multicenter ACRIN 6684 Trial 2020 ·Tomography ·Mark Muzi, Eric Wolsztynski, James R. Fink, Janet OʼSullivan, Finbarr O’Sullivan, Kenneth A. Krohn, David A. Mankoff	20
10	Positron Emission Tomography Imaging of [¹¹C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A 2019 ·Clinical Pharmacology & Therapeutics ·Sarah Billington, Steven C. Shoner, Scott D. Lee, Kindra Clark‐Snustad, (unknown), David H. Lewis, Mark Muzi, (unknown), Jean Lee, Tot Bui Nguyen, Vineet Kumar, Kazuya Ishida, Laigao Chen, Xiaoyan Chu, Yurong Lai, Laurent Salphati, Cornelis E. C. A. Hop, Guangqing Xiao, Mingxiang Liao, Jashvant D. Unadkat	50
11	ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy 2018 ·PLoS ONE ·Eva‐Maria Ratai, Zheng Zhang, James R. Fink, Mark Muzi, Lucy Hanna, Erin Greco, Todd L. Richards, Daniel J. Kim, Ovidiu C. Andronesi, Akiva Mintz, Lale Kostakoglu, Melissa Prah, Benjamin M. Ellingson, Kathleen M. Schmainda, Gregory Sorensen, Daniel P. Barboriak, David A. Mankoff, Elizabeth R. Gerstner, (unknown)	20
12	Test–Retest Reproducibility of ¹⁸F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network 2018 ·Journal of Nuclear Medicine ·Brenda F. Kurland, Lanell M. Peterson, Andrew Shields, Jean H. Lee, (unknown), Alena Novakova-Jiresova, Mark Muzi, Jennifer M. Specht, David A. Mankoff, Hannah M. Linden, Paul E. Kinahan	22
13	A virtual clinical trial comparing static versus dynamic PET imaging in measuring response to breast cancer therapy 2017 ·Physics in Medicine and Biology ·(unknown), Mark Muzi, Lanell M. Peterson, Hannah M. Linden, Alena Nováková, David A. Mankoff, Paul E. Kinahan	15
14	ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI 2016 ·Clinical Cancer Research ·Elizabeth R. Gerstner, Zheng Zhang, James R. Fink, Mark Muzi, Lucy Hanna, Erin Greco, Melissa Prah, Kathleen M. Schmainda, Akiva Mintz, Lale Kostakoglu, Edward A. Eikman, Benjamin M. Ellingson, Eva‐Maria Ratai, A. Gregory Sorensen, Daniel P. Barboriak, David A. Mankoff	85
15	Effect of 18F-FDG Uptake Time on Lesion Detectability in PET Imaging of Early-Stage Breast Cancer 2015 ·Tomography ·(unknown), Mark Muzi, Lanell M. Peterson, Hannah M. Linden, (unknown), Finbarr O’Sullivan, (unknown), David A. Mankoff, Paul E. Kinahan	1
16	Effects of dasatinib on prostate cancer bone metastases and normal bone measured by 18F-fluoride PET: Preliminary results from ACRIN 6687 2013 ·Evan Y. Yu, Fenghai Duan, Mark Muzi, Jeremy Gorelick, Bennett B. Chin, Joshi J. Alumkal, Mary‐Ellen Taplin, Robert K. Doot, Phillip G. Febbo, David A. Mankoff	2
17	Quantitative Metrics of Net Proliferation and Invasion Link Biological Aggressiveness Assessed by MRI with Hypoxia Assessed by FMISO-PET in Newly Diagnosed Glioblastomas 2009 ·Cancer Research ·Mindy D Szeto, (unknown), Jennifer Hadley, Russell C. Rockne, Mark Muzi, Ellsworth C. Alvord, Kenneth A. Krohn, Alexander M. Spence, Kristin R. Swanson	121
18	Positron emission tomography imaging of tissue P‐glycoprotein activity during pregnancy in the non‐human primate 2009 ·British Journal of Pharmacology ·(unknown), Sara Eyal, Mark Muzi, J. M. Link, (unknown), Amal Kaddoumi, Finbarr O’Sullivan, Peng Hsiao, Jashvant D. Unadkat	26
19	[F-18]-fluoromisonidazole (FMISO) PET demonstrates reduced hypoxia in recurrent malignant gliomas that respond to bevacizumab and irinotecan 2007 ·Molecular Cancer Therapeutics ·Alexander M. Spence, Mark Muzi, Maciej Mrugala, Tom Christian Holm Adamsen, Jeanne M. Link, Kenneth Krohn	1
20	Verapamil P-glycoprotein Transport across the Rat Blood-Brain Barrier: Cyclosporine, a Concentration Inhibition Analysis, and Comparison with Human Data 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Peng Hsiao, Lucy Sasongko, Jeanne M. Link, David A. Mankoff, Mark Muzi, Ann C. Collier, Jashvant D. Unadkat	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact